AID-DCM
Research type
Research Study
Full title
AcceeratIng Diagnosis of Degenerative Cervical Myelopathy of individuals presenting with symptoms compatible with Degenerative Cervical Myelopathy (DCM)
IRAS ID
277620
Contact name
Stephen Kelleher
Contact email
Sponsor organisation
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
Clinicaltrials.gov Identifier
n/a, n/a
Duration of Study in the UK
3 years, 6 months, 1 days
Research summary
Degenerative cervical myelopathy (DCM) is a disease of the spinal cord in the neck, caused when it is affected by arthritis of the spine. It can cause a range of whole-body symptoms, including altered sensation, pain, imbalance and falls, weakness and loss of dexterity. Unfortunately, patients today wait years for a diagnosis, and this makes treatment far less effective. Hence, finding ways to diagnose the condition earlier is a critical priority.
The primary purpose of this study is to characterise the symptoms of DCM, including at the onsent and with progression, using a symptomatology questionnaire (Myelopathy.org Symptom Inventory, MOSI) and a new smartphone-based tool (MoveMed app).
The MOSI is essentially a questionnaire which is designed to assess your experience of DCM, and its impact on your day-to-day life, at this moment in time. It has been developed in collaboration with Myelopathy.org, a UK charity and its online community of patients. The MoveMed app has been developed to screen and monitor degenerative cervical myelopathy, in collaboration with Myelopathy.org, a UK Charity for DCM. To do so, we need to follow a group of patients who may turn out to have DCM.
The secondary objective is to assess the predictive ability of both tools in terms of DCM monitoring.REC name
South Central - Oxford C Research Ethics Committee
REC reference
22/SC/0218
Date of REC Opinion
8 Jul 2022
REC opinion
Favourable Opinion